Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suzetrigine for Post-operative Pain in Total Knee Replacement
NCT07548385Phase 3Recruiting
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Apr 2026
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of suzetrigine in postoperative pain, sponsored by Icahn School of Medicine at Mount Sinai. Started Apr 2026; status: recruiting.
02
Drugs
suzetrigine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07548385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07548385.